VALEANT PHARMACEUTICALS INTE's ticker is and the CUSIP is 91911K953. A total of 1 filers reported holding VALEANT PHARMACEUTICALS INTE in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $46,000 | -24.6% | 4,200 | 0.0% | 0.00% | – |
| Q4 2016 | $61,000 | -99.9% | 4,200 | 0.0% | 0.00% | – |
| Q3 2016 | $103,051,000 | +21.7% | 4,200 | 0.0% | 0.00% | – |
| Q2 2016 | $84,686,000 | -23.0% | 4,200 | 0.0% | 0.00% | – |
| Q1 2016 | $110,000,000 | -74.2% | 4,200 | 0.0% | 0.00% | -100.0% |
| Q4 2015 | $427,000,000 | +56833.3% | 4,200 | 0.0% | 0.00% | -33.3% |
| Q3 2015 | $750,000 | -99.9% | 4,200 | -6.7% | 0.00% | -25.0% |
| Q2 2015 | $998,251,000 | +54.9% | 4,500 | 0.0% | 0.00% | +33.3% |
| Q4 2014 | $644,246,000 | +9.3% | 4,500 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $589,647,000 | +3.6% | 4,500 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $569,074,000 | – | 4,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JPMORGAN CHASE & CO | 7,100 | $740,000 | 0.00% |